vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Village Farms International, Inc. (VFF). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $12.2M, roughly 1.6× Village Farms International, Inc.). Village Farms International, Inc. runs the higher net margin — 19.9% vs -541.1%, a 561.0% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 31.5%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Grafton Village Cheese Company is a cheesemaker in the town of Grafton in the U.S. state of Vermont. The company produces hand-crafted aged cheddar cheese.
AGIO vs VFF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $12.2M |
| Net Profit | $-108.0M | $2.4M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | — |
| Net Margin | -541.1% | 19.9% |
| Revenue YoY | 86.1% | 31.5% |
| Net Profit YoY | -11.9% | 128.2% |
| EPS (diluted) | $-1.86 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $12.2M | ||
| Q3 25 | $12.9M | $66.7M | ||
| Q2 25 | $12.5M | $59.9M | ||
| Q1 25 | $8.7M | $77.1M | ||
| Q4 24 | $10.7M | — | ||
| Q3 24 | $9.0M | $54.9M | ||
| Q2 24 | $8.6M | $53.6M | ||
| Q1 24 | $8.2M | $78.1M |
| Q4 25 | $-108.0M | $2.4M | ||
| Q3 25 | $-103.4M | $10.2M | ||
| Q2 25 | $-112.0M | $26.5M | ||
| Q1 25 | $-89.3M | $-6.7M | ||
| Q4 24 | $-96.5M | — | ||
| Q3 24 | $947.9M | $-820.0K | ||
| Q2 24 | $-96.1M | $-23.5M | ||
| Q1 24 | $-81.5M | $-2.9M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | 47.9% | ||
| Q2 25 | 86.3% | 37.3% | ||
| Q1 25 | 87.6% | 14.7% | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | 24.8% | ||
| Q2 24 | 82.6% | 25.4% | ||
| Q1 24 | 92.3% | 19.9% |
| Q4 25 | -608.9% | — | ||
| Q3 25 | -907.4% | 23.3% | ||
| Q2 25 | -1020.1% | 20.8% | ||
| Q1 25 | -1222.0% | -8.0% | ||
| Q4 24 | -1165.3% | — | ||
| Q3 24 | -1146.9% | 3.8% | ||
| Q2 24 | -1228.3% | -43.5% | ||
| Q1 24 | -1124.3% | -3.0% |
| Q4 25 | -541.1% | 19.9% | ||
| Q3 25 | -803.1% | 15.3% | ||
| Q2 25 | -899.4% | 44.2% | ||
| Q1 25 | -1023.3% | -8.7% | ||
| Q4 24 | -899.6% | — | ||
| Q3 24 | 10574.7% | -1.5% | ||
| Q2 24 | -1115.7% | -43.9% | ||
| Q1 24 | -995.8% | -3.7% |
| Q4 25 | $-1.86 | $0.01 | ||
| Q3 25 | $-1.78 | $0.08 | ||
| Q2 25 | $-1.93 | $0.24 | ||
| Q1 25 | $-1.55 | $-0.06 | ||
| Q4 24 | $-1.44 | — | ||
| Q3 24 | $16.22 | $-0.01 | ||
| Q2 24 | $-1.69 | $-0.21 | ||
| Q1 24 | $-1.45 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $81.2M |
| Total DebtLower is stronger | — | $33.7M |
| Stockholders' EquityBook value | $1.2B | $299.9M |
| Total Assets | $1.3B | $423.1M |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $81.2M | ||
| Q3 25 | $92.7M | $82.6M | ||
| Q2 25 | $80.9M | $60.0M | ||
| Q1 25 | $79.0M | $15.1M | ||
| Q4 24 | $76.2M | — | ||
| Q3 24 | $253.7M | $28.7M | ||
| Q2 24 | $84.5M | $29.7M | ||
| Q1 24 | $118.8M | $26.7M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | — | $34.6M | ||
| Q2 25 | — | $39.1M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $43.3M | ||
| Q2 24 | — | $44.4M | ||
| Q1 24 | — | $46.1M |
| Q4 25 | $1.2B | $299.9M | ||
| Q3 25 | $1.3B | $295.4M | ||
| Q2 25 | $1.4B | $284.3M | ||
| Q1 25 | $1.5B | $248.3M | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.6B | $274.4M | ||
| Q2 24 | $660.5M | $275.2M | ||
| Q1 24 | $743.9M | $296.2M |
| Q4 25 | $1.3B | $423.1M | ||
| Q3 25 | $1.4B | $418.4M | ||
| Q2 25 | $1.5B | $403.7M | ||
| Q1 25 | $1.6B | $377.1M | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.8B | $417.8M | ||
| Q2 24 | $773.1M | $425.4M | ||
| Q1 24 | $849.7M | $458.4M |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | — |
| Free Cash FlowOCF − Capex | $-97.3M | — |
| FCF MarginFCF / Revenue | -487.5% | — |
| Capex IntensityCapex / Revenue | 5.6% | 90.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | — | ||
| Q3 25 | $-88.2M | $24.4M | ||
| Q2 25 | $-77.1M | — | ||
| Q1 25 | $-111.5M | $-6.4M | ||
| Q4 24 | $-133.2M | — | ||
| Q3 24 | $-84.2M | $4.3M | ||
| Q2 24 | $-72.6M | $5.7M | ||
| Q1 24 | $-99.9M | $-50.0K |
| Q4 25 | $-97.3M | — | ||
| Q3 25 | $-89.7M | $22.6M | ||
| Q2 25 | $-78.0M | — | ||
| Q1 25 | $-112.3M | $-8.9M | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | $1.5M | ||
| Q2 24 | $-72.7M | $4.8M | ||
| Q1 24 | $-100.0M | $-1.9M |
| Q4 25 | -487.5% | — | ||
| Q3 25 | -696.5% | 33.9% | ||
| Q2 25 | -626.2% | — | ||
| Q1 25 | -1286.4% | -11.6% | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | 2.7% | ||
| Q2 24 | -844.4% | 9.0% | ||
| Q1 24 | -1221.2% | -2.5% |
| Q4 25 | 5.6% | 90.8% | ||
| Q3 25 | 12.1% | 2.7% | ||
| Q2 25 | 7.0% | 4.6% | ||
| Q1 25 | 8.8% | 3.3% | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.7% | 5.1% | ||
| Q2 24 | 1.8% | 1.6% | ||
| Q1 24 | 1.7% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
VFF
| International Sales | $8.7M | 71% |
| Cannabis United States Segment | $3.4M | 27% |
